financetom
Business
financetom
/
Business
/
Cisco Systems Beats Fourth-Quarter Views Amid Demand Momentum
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Cisco Systems Beats Fourth-Quarter Views Amid Demand Momentum
Aug 13, 2025 2:17 PM

04:45 PM EDT, 08/13/2025 (MT Newswires) -- Cisco Systems' ( CSCO ) fiscal fourth-quarter results surpassed Wall Street's estimates as demand for the networking equipment maker's products grew.

Adjusted per-share earnings rose to $0.99 during the three months ended July 26 from $0.87 a year earlier, beating the $0.98 consensus estimate on FactSet. Revenue increased 8% to $14.67 billion, compared with the Street's $14.62 billion view.

Product sales grew 10% to $10.89 billion, driven by double-digit gains in networking. The services segment edged higher to $3.79 billion from $3.78 billion. Artificial intelligence infrastructure orders from web-scale customers topped $800 million, lifting the full-year tally above $2 billion, compared with the company's original $1 billion target.

Tigress Financial Intelligence was expecting strong results driven by order growth from webscale customers and hyperscalers.

"Cisco ( CSCO ) continues to benefit from high-speed AI-driven data center network connectivity driven by robust demand for its AI-driven network infrastructure," Tigress said in a note on Monday.

Cisco ( CSCO ) forecasts fiscal 2026 adjusted EPS of $4 to $4.06 on revenue between $59 billion and $60 billion. Analysts polled by FactSet expect normalized EPS of $4.02 and revenue of $59.39 billion.

For the first quarter, Cisco ( CSCO ) projects adjusted EPS of $0.97 to $0.99 and revenue between $14.65 billion and $14.85 billion. The consensus estimates are $0.97 and $14.62 billion, respectively.

Shares were down 2.5% in after-hours trade. The stock has gained nearly 19% so far this year.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Britain proposes obligations on Mastercard and Visa to increase competition
Britain proposes obligations on Mastercard and Visa to increase competition
May 20, 2024
LONDON, May 21 (Reuters) - There is no effective competition in core credit card services where Visa and Mastercard ( MA ) are the biggest players, and more transparency for users is needed, Britain's Payment Systems Regulator said in an interim report on Tuesday. The PSR found that over the past five years, and after taking account of volume changes,...
Britain proposes obligations on Mastercard and Visa to increase competition
Britain proposes obligations on Mastercard and Visa to increase competition
May 20, 2024
LONDON (Reuters) - There is no effective competition in core credit card services where Visa and Mastercard ( MA ) are the biggest players, and more transparency for users is needed, Britain's Payment Systems Regulator said in an interim report on Tuesday. The PSR found that over the past five years, and after taking account of volume changes, Mastercard (...
Sanofi partners with OpenAI, Formation Bio on AI-driven drug development
Sanofi partners with OpenAI, Formation Bio on AI-driven drug development
May 20, 2024
May 21 (Reuters) - French drugmaker Sanofi on Tuesday announced it is collaborating with artificial intelligence company OpenAI and Formation Bio to boost its drug development projects through the use of Artificial Intelligence. Sanofi said in a statement that the partnership with OpenAi will allow it to access proprietary data to develop AI models for its biopharma models, while Formation...
Sanofi partners with OpenAI, Formation Bio on AI-driven drug development
Sanofi partners with OpenAI, Formation Bio on AI-driven drug development
May 20, 2024
(Reuters) - French drugmaker Sanofi on Tuesday announced it is collaborating with artificial intelligence company OpenAI and Formation Bio to boost its drug development projects through the use of Artificial Intelligence. Sanofi said in a statement that the partnership with OpenAi will allow it to access proprietary data to develop AI models for its biopharma models, while Formation Bio will...
Copyright 2023-2026 - www.financetom.com All Rights Reserved